Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Dual or Triple Therapy for Maintenance of COPD: A Review
Advertisement
Advertisement
Trending on AJMC
1
Bringing CAR T-Cell Therapy Into Community Cancer Centers
2
The True Cost of Running a Community CAR T-Cell Program
3
Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute
4
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
5